In contrast, we recently found a significantly increased FECH mRNA expression in WHO grade IV compared to WHO grade II gliomas in a large “The Cancer Genome Atlas” (TCGA) cohort including 424 glioma samples (36). This evidence concerns the gene FECH and central nervous system cancer.